DK0655243T3 - Melatoninderivater til anvendelse ved behandling af søvnlidelser - Google Patents

Melatoninderivater til anvendelse ved behandling af søvnlidelser

Info

Publication number
DK0655243T3
DK0655243T3 DK94308466T DK94308466T DK0655243T3 DK 0655243 T3 DK0655243 T3 DK 0655243T3 DK 94308466 T DK94308466 T DK 94308466T DK 94308466 T DK94308466 T DK 94308466T DK 0655243 T3 DK0655243 T3 DK 0655243T3
Authority
DK
Denmark
Prior art keywords
sleep disorders
treatment
melatonin derivatives
melatonin
derivatives
Prior art date
Application number
DK94308466T
Other languages
Danish (da)
English (en)
Inventor
Michael Edward Flaugh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0655243T3 publication Critical patent/DK0655243T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94308466T 1993-11-18 1994-11-16 Melatoninderivater til anvendelse ved behandling af søvnlidelser DK0655243T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/154,332 US5654325A (en) 1993-11-18 1993-11-18 Melatonin derivatives for use in treating sleep disorders

Publications (1)

Publication Number Publication Date
DK0655243T3 true DK0655243T3 (da) 2002-10-07

Family

ID=22550932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94308466T DK0655243T3 (da) 1993-11-18 1994-11-16 Melatoninderivater til anvendelse ved behandling af søvnlidelser

Country Status (21)

Country Link
US (1) US5654325A (de)
EP (1) EP0655243B1 (de)
JP (1) JPH07196493A (de)
KR (1) KR950013508A (de)
CN (1) CN1092958C (de)
AT (1) ATE222491T1 (de)
AU (1) AU684313B2 (de)
CA (1) CA2135709C (de)
CZ (1) CZ288835B6 (de)
DE (1) DE69431199T2 (de)
DK (1) DK0655243T3 (de)
ES (1) ES2181702T3 (de)
HU (1) HUT72069A (de)
IL (1) IL111580A (de)
NO (1) NO309964B1 (de)
NZ (1) NZ264892A (de)
PH (1) PH31098A (de)
PT (1) PT655243E (de)
RU (1) RU2146140C1 (de)
SG (1) SG50505A1 (de)
ZA (1) ZA948927B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748627A3 (de) * 1995-06-14 1997-05-21 Lilly Co Eli Melatoninagonisten zur Behandlung von gutartigen Hyperplasieformen der Prostata
CA2357114C (en) * 2001-03-22 2010-06-29 Pooger Properties Ltd. Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
ES2287512T3 (es) * 2002-09-26 2007-12-16 Pooger Properties Limited Utilizacion combinada de metilfenidato y melatonina para el tratamiento de la enfermedad de hiperactividad con deficit de atencion.
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
WO2005062851A2 (en) * 2003-12-22 2005-07-14 Pappolla Miguel A Indole-3-propionamide and derivatives thereof
US7799817B2 (en) * 2004-02-20 2010-09-21 Lifescape Biosciences Inc Compositions and methods for sleep regulation
DE102005008312A1 (de) * 2005-02-17 2006-08-24 Birds Pharma Gmbh Berolina Innovative Research & Development Services Verwendung deuterierter N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]acatamide und deren pharmazeutisch verträglicher Salze sowie diese Verbindungen enthaltende Arzneimittel
US20060223877A1 (en) * 2005-03-31 2006-10-05 Zemlan Frank P Methods of treatment utilizing certain melatonin derivatives
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物
ES2324849A1 (es) * 2007-10-25 2009-08-17 Ferrer Internacional, S.A. Compuestos de indano.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
EP0126630B1 (de) * 1983-05-18 1987-09-16 Monash University Verwendung von Melatonin zur Herstellung eines Arzneimittels
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
US5093352A (en) * 1988-11-14 1992-03-03 Whitby Research, Inc. Antidepressant agents
WO1989001472A1 (en) * 1987-08-17 1989-02-23 Nelson Research & Development Co. Melatonin analogues
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
IT1255199B (it) * 1992-07-01 1995-10-20 Franco Fraschini Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin

Also Published As

Publication number Publication date
NO944339D0 (no) 1994-11-14
JPH07196493A (ja) 1995-08-01
DE69431199T2 (de) 2003-03-27
PT655243E (pt) 2002-11-29
NO309964B1 (no) 2001-04-30
HUT72069A (en) 1996-03-28
IL111580A0 (en) 1995-01-24
EP0655243A3 (de) 1995-10-11
NZ264892A (en) 1997-07-27
AU684313B2 (en) 1997-12-11
EP0655243A2 (de) 1995-05-31
DE69431199D1 (de) 2002-09-26
RU2146140C1 (ru) 2000-03-10
CZ288835B6 (cs) 2001-09-12
IL111580A (en) 1999-10-28
HU9403300D0 (en) 1995-01-30
PH31098A (en) 1998-02-05
CN1107701A (zh) 1995-09-06
CN1092958C (zh) 2002-10-23
AU7777794A (en) 1995-05-25
ES2181702T3 (es) 2003-03-01
SG50505A1 (en) 1998-07-20
KR950013508A (ko) 1995-06-15
US5654325A (en) 1997-08-05
ZA948927B (en) 1996-05-10
NO944339L (no) 1995-05-19
CA2135709C (en) 2007-01-02
ATE222491T1 (de) 2002-09-15
EP0655243B1 (de) 2002-08-21
RU94040886A (ru) 1996-09-20
CA2135709A1 (en) 1995-05-19
CZ276594A3 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
DK1002534T3 (da) Anvendelse af fire K-252a-derivater
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
EP0467164A3 (en) Use of the compound flupirtine against muscle bracing
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK0656209T3 (da) Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DK0693912T3 (da) Apparat til medicinsk behandling
DE69800906D1 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis
FI945035A (fi) Pintasterilisointi laserkäsittelyn avulla
DK236489A (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
NO944055D0 (no) Overflatesterilisering ved laserbehandling
ITMI920106A0 (it) Composizioni farmaceutiche comprendenti melatonina o un suo derivato-agonista atte al trattamento dei disordini cerebro-vascolari
DK31793D0 (da) Haandstykke for odontologisk laserbehandling
ITRM920002A1 (it) Procedimento per il trattamento disinquinante, di residui contenenti caprolattame.